The role of systematic review in market access
Modern market access activities need to be evidence-based. But what does this really mean for new products being taken to market around the world?
Read More
Section: Sales
Interview: John Dineen, GE Healthcare
GE Healthcare’s president and CEO tells Dominic Tyer about the rising importance of molecular diagnostics and how his company is moving increasingly closer to the biopharmaceutical world
Read MoreMiracles and mistakes in strategic planning
What happens when we allow conscious thought and experience to cloud our thinking?
Read More
Strategic planning – it’s not rocket science…
… but maximising opportunities does demand new concepts and ideas
Read More
Interview: Joseph Jimenez, Novartis
Novartis’ CEO tells Linda Banks how investing in innovation and parallel development is helping to keep the company at the forefront
Read More